Lung Cancer Therapeutics – A Global Market Overview

This global Lung Cancer Therapeutics report analyzes the market based on Cancer Type (Non-small cell lung cancer NSCLC, Small cell lung cancer SCLC), Therapy Type (Targeted Therapies, Immunotherapy, Chemotherapy, Radiation Therapy, Others), End-User (Hospitals, Specialty Clinics, Other End-Users) , and by geographic region (North America, Europe, Asia-Pacific, South America and Rest of World for 2021-2030 period in terms of value in US$ million, projected from 2024 through 2030. The global market for Lung Cancer Therapeutics is estimated at US$32.5 billion in 2024 and is anticipated to record a CAGR of 10.4% during the 2024-2030 analysis period and stand at a projected US$58.9 billion by 2030.

本全球肺癌治疗药物市场报告基于癌症类型（非小细胞肺癌NSCLC、小细胞肺癌SCLC）、治疗类型（靶向治疗、免疫治疗、化疗、放射治疗、其他）、终端用户（医院、专科诊所、其他终端用户）以及地理区域（北美、欧洲、亚太地区、南美洲及世界其他地区）对2021-2030年期间的全球肺癌治疗药物市场进行分析。以2021-2030年期间的美元百万计价值计算，预计从2024年至2030年，全球肺癌治疗药物市场规模估计为325亿美元，预计在2024-2030年分析期间实现10.4%的复合年增长率，并在2030年达到预计的589亿美元。